Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Anthrogenesis_Corporation
|
| gptkbp:CEO |
gptkb:Robert_J._Hariri
|
| gptkbp:collaboratedWith |
gptkb:Sorrento_Therapeutics
|
| gptkbp:focusesOn |
regenerative medicine
immunotherapy cellular medicine |
| gptkbp:foundedBy |
gptkb:Robert_J._Hariri
|
| gptkbp:foundedYear |
2017
|
| gptkbp:headquartersLocation |
gptkb:Florham_Park,_New_Jersey,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Celularity
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableInvestment |
gptkb:Human_Longevity_Inc.
gptkb:Celgene gptkb:United_Therapeutics Section 32 |
| gptkbp:notableProduct |
biologic therapies derived from placental cells
|
| gptkbp:publiclyTraded |
yes
|
| gptkbp:stockSymbol |
gptkb:CELU
|
| gptkbp:website |
https://www.celularity.com/
|
| gptkbp:bfsParent |
gptkb:Robert_Hariri
|
| gptkbp:bfsLayer |
7
|